You are viewing: South Korea Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The South Korea Latent TB Testing Market was valued at $9.36 Million in 2024 and projected to reach to $12.94 Million by 2029, representing a compound annual growth rate of 6.7%. South Korea's latent TB testing market is positioned for sustained growth through 2029, driven by the nation's commitment to tuberculosis elimination and integration of advanced diagnostic technologies.

South Korea Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Latent TB Testing Market Trends and Insights

  • This growth trajectory reflects South Korea's commitment to tuberculosis control and early detection strategies within its advanced healthcare infrastructure.
  • South Korea's emphasis on preventive medicine and screening programs continues to drive demand for latent TB diagnostic solutions. The latent TB testing market in South Korea is supported by increasing awareness of tuberculosis transmission risks and the country's robust public health initiatives.
  • South Korea's healthcare system prioritizes early identification of latent TB infections to prevent progression to active disease.
  • Between 2024 and 2029, South Korea is expected to see accelerated adoption of innovative testing methodologies and expanded screening coverage across occupational and clinical settings. South Korea's market growth is underpinned by technological advancements in diagnostic accuracy and integration with digital health platforms.
  • South Korea's regulatory environment and healthcare investment create favorable conditions for market expansion through 2029..

Key Market Statistics

  • CAGR (2024-2029) 6.7% CAGR
  • Market Size, 2024 ~USD 9.36 Million
  • Forecast, 2029 ~USD 12.94 Million
  • Country South Korea

South Korea Latent TB Testing Market Overview

Market Valuation Growth :

South Korea's latent TB testing market is valued at $9.36 million in 2024, with a projected CAGR of 6.7% through 2029, reaching $12.94 million. This outpaces the global CAGR of 5.8%, indicating stronger regional momentum.

Advanced Healthcare Infrastructure :

South Korea's sophisticated healthcare system and high diagnostic technology adoption enable rapid integration of latent TB testing innovations, supporting market expansion and improved screening accessibility across urban and rural regions.

Preventive Medicine Focus :

South Korea's healthcare policy prioritizes preventive screening and early disease detection. This cultural and institutional emphasis on proactive health management directly drives demand for latent TB testing among at-risk populations and healthcare facilities.

TB Control Strategy Alignment :

National tuberculosis control programs in South Korea increasingly incorporate latent TB identification as a cornerstone strategy. Government initiatives and public health campaigns support market growth through expanded screening mandates and funding allocation.

South Korea Latent TB Testing Market Dynamics

  • The 6.7% CAGR reflects increasing adoption of interferon-gamma release assays and tuberculin skin tests across healthcare providers, occupational health programs, and immigration screening protocols.
  • South Korea's aging population and rising healthcare expenditure further support market expansion. Government-backed TB control initiatives and mandatory screening requirements for healthcare workers and vulnerable populations will continue to fuel demand.
  • Investment in point-of-care testing solutions and digital health integration presents additional growth opportunities.
  • The market will benefit from South Korea's strong regulatory framework, high healthcare spending per capita, and emphasis on infectious disease surveillance, positioning it as a key regional market for latent TB testing solutions..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • South Korea's latent TB testing market is valued at $9.36 million in 2024 and is forecast to reach $12.94 million by 2029, representing a 6.7% CAGR.
    • South Korea's advanced healthcare infrastructure and preventive medicine focus drive consistent demand for latent TB diagnostic solutions.
    • South Korea's market growth is supported by increased screening awareness, occupational health programs, and public health initiatives targeting TB control.
    • South Korea's adoption of innovative diagnostic technologies and digital health integration positions the market for sustained expansion through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    South Korea Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    Target Audience

    • In Vitro Diagnostics Manufacturers : IVD companies developing latent TB testing solutions need South Korea market data to assess market size, growth potential, and competitive positioning. This enables informed product development, pricing strategy, and market entry decisions for this high-growth regional market.
    • Healthcare System Administrators : Hospital networks, public health agencies, and healthcare administrators in South Korea require market insights to optimize TB screening program budgets, procurement strategies, and resource allocation aligned with national TB control objectives.
    • Medical Device Distributors & Importers : South Korea-based distributors and medical device importers need market forecasts and competitive analysis to identify growth opportunities, negotiate supplier agreements, and develop effective distribution strategies for latent TB testing products.
    • Investment & Private Equity Firms : Investors evaluating opportunities in South Korea's healthcare sector require detailed market data on latent TB testing to assess investment returns, identify acquisition targets, and understand market growth catalysts and risk factors.
    • Government & Public Health Officials : South Korean health ministry officials and TB control program managers use market intelligence to inform policy decisions, budget allocations, and strategic planning for national tuberculosis elimination initiatives and screening programs.

    Reasons to Buy this Report

    • Market-Specific Growth Projections : Access detailed South Korea market forecasts with 6.7% CAGR through 2029. Understand regional growth drivers and market dynamics specific to South Korea's healthcare landscape, enabling precise business planning and investment decisions.
    • Competitive Landscape Intelligence : Gain insights into South Korea's latent TB testing market structure, key players, and competitive positioning. Identify market gaps and opportunities unique to South Korea's advanced healthcare system and regulatory environment.
    • Healthcare Policy & Regulatory Insights : Understand South Korea's TB control strategies, screening mandates, and government initiatives driving market demand. Align product development and market entry strategies with national health policies and reimbursement frameworks.
    • Segment & Application Analysis : Explore South Korea-specific market segments including occupational health screening, immigration testing, and clinical diagnostics. Identify high-growth applications and target customer segments within South Korea's healthcare ecosystem.
    • Strategic Market Entry Planning : Leverage South Korea-focused market data to develop localized go-to-market strategies. Understand healthcare provider preferences, pricing dynamics, and distribution channels specific to South Korea's advanced medical device market.

    Frequently asked questions

    What is the current size of South Korea's latent TB testing market?

    South Korea's latent TB testing market was valued at $9.36 million in 2024 and is expected to grow to $12.94 million by 2029.

    What is the projected growth rate for South Korea's latent TB testing market?

    South Korea's latent TB testing market is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2029.

    What factors are driving growth in South Korea's latent TB testing market?

    South Korea's market growth is driven by advanced healthcare infrastructure, preventive medicine emphasis, increased screening awareness, occupational health programs, and public health TB control initiatives.

    Which testing methodologies are most prevalent in South Korea's latent TB market?

    South Korea's latent TB testing market includes interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), with increasing adoption of innovative diagnostic technologies integrated with digital health platforms.

    How does South Korea's healthcare system support latent TB testing expansion?

    South Korea's healthcare system supports latent TB testing through regulatory frameworks, public health initiatives, occupational screening programs, and investment in diagnostic infrastructure and digital health integration.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status